Considerations in the development and validation of real-time quantitative polymerase chain reaction and its application in regulated bioanalysis to characterize the cellular kinetics of CAR-T products in clinical studies

被引：10
作者：
Yang, Tong-yuan [1 ]
Doddareddy, Rajitha [1 ]
机构：
[1] Janssen Res & Dev LLC, Janssen BioTherapeut, 1400 McKean Rd, Spring House, PA 19477 USA
来源：
BIOANALYSIS | 2021年 / 13卷 / 02期
关键词：
assay development and validation; CAR-T; cellular kinetics; qPCR; regulated bioanalysis; LIGAND-BINDING ASSAYS; PCR ASSAYS; CELLS; QUANTIFICATION; REVOLUTION; SUPPORT; DNA;
D O I：
10.4155/bio-2020-0221
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
Real-time quantitative polymerase chain reaction (qPCR) has become the standard method for monitoring cellular kinetics of CAR-T therapies with measurement of the CAR transgene copy numbers in peripheral blood mononuclear cells isolated from patients receiving the treatment. Unlike other biophysical and immunological methodologies for bioanalytical characterization of conventional small molecule drugs or protein biologics, there is no relevant regulatory guidance to date on the method development and validation for quantitative qPCR assays employed during clinical development of CAR-T products. This paper will provide an overview and considerations in the development and validation of a qPCR assay from sample extraction to assay parameters and its implementation in regulated bioanalysis for CAR-T or other types of cell therapies.
引用
收藏
页码：115 / 128
页数：14
相关论文
共 26 条
  • [1] Inhibition Controls for Qualitative Real-Time PCR Assays: Are They Necessary for All Specimen Matrices?
    Buckwalter, S. P.
    Sloan, L. M.
    Cunningham, S. A.
    Espy, M. J.
    Uhl, J. R.
    Jones, M. F.
    Vetter, E. A.
    Mandrekar, J.
    Cockerill, F. R., III
    Pritt, B. S.
    Patel, R.
    Wengenack, N. L.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (06) : 2139 - 2143
  • [2] Bustin Stephen, 2017, Biomol Detect Quantif, V14, P19, DOI 10.1016/j.bdq.2017.11.001
  • [3] The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
    Bustin, Stephen A.
    Benes, Vladimir
    Garson, Jeremy A.
    Hellemans, Jan
    Huggett, Jim
    Kubista, Mikael
    Mueller, Reinhold
    Nolan, Tania
    Pfaffl, Michael W.
    Shipley, Gregory L.
    Vandesompele, Jo
    Wittwer, Carl T.
    [J]. CLINICAL CHEMISTRY, 2009, 55 (04) : 611 - 622
  • [4] CAR-T Cells: Future Perspectives
    Charrot, Sarah
    Hallam, Simon
    [J]. HEMASPHERE, 2019, 3 (02):
  • [5] Development of a robust DNA quality and quantity assessment qPCR assay for targeted next-generation sequencing library preparation
    Dang, Jennifer
    Mendez, Pedro
    Lee, Sharon
    Kim, James W.
    Yoon, Jun-Hee
    Kim, Thomas W.
    Sailey, Charles J.
    Jablons, David M.
    Kim, Il-Jin
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (04) : 1755 - 1765
  • [6] Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules
    DeSilva, B
    Smith, W
    Weiner, R
    Kelley, M
    Smolec, JM
    Lee, B
    Khan, M
    Tacey, R
    Hill, H
    Celniker, A
    [J]. PHARMACEUTICAL RESEARCH, 2003, 20 (11) : 1885 - 1900
  • [7] European Medicines Agency, 2012, GUID BIOAN METH VAL
  • [8] Digital PCR Assays for Precise Quantification of CD19-CAR-T Cells after Treatment with Axicabtagene Ciloleucel
    Fehse, Boris
    Badbaran, Anita
    Berger, Carolina
    Sonntag, Tanja
    Riecken, Kristoffer
    Geffken, Maria
    Kroeger, Nicolaus
    Ayuk, Francis A.
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 16 : 172 - 178
  • [9] Forootan Amin, 2017, Biomol Detect Quantif, V12, P1, DOI 10.1016/j.bdq.2017.04.001
  • [10] Geist BJ, 2013, BIOANALYSIS, V5, P227, DOI [10.4155/BIO.12.304, 10.4155/bio.12.304]
123